BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/26/2024 4:10:19 AM | Browse: 307 | Download: 898
 |
Received |
|
2023-11-30 08:22 |
|
Peer-Review Started |
|
2023-11-30 08:22 |
|
First Decision by Editorial Office Director |
|
2023-12-17 01:42 |
|
Return for Revision |
|
2023-12-17 01:42 |
|
Revised |
|
2024-01-04 10:17 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-01-29 02:04 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-01-29 06:16 |
|
Articles in Press |
|
2024-01-29 06:16 |
|
Edit the Manuscript by Language Editor |
|
2024-01-25 12:04 |
|
Typeset the Manuscript |
|
2024-02-18 05:44 |
|
Publish the Manuscript Online |
|
2024-02-26 04:10 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Respiratory System |
| Manuscript Type |
Review |
| Article Title |
Therapeutic utility of human umbilical cord-derived mesenchymal stem cells-based approaches in pulmonary diseases: Recent advancements and prospects
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Min Meng, Wei-Wei Zhang, Shuang-Feng Chen, Da-Rui Wang and Chang-Hui Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chang-Hui Zhou, MD, Doctor, Doctor, Department of Central Laboratory, Liaocheng People’s Hospital, No. 67 Dongchang West Road, Liaocheng 252000, Shandong Province, China. zhouchanghui008@163.com |
| Key Words |
Pulmonary diseases; Mesenchymal stem cells; Human umbilical cord; Cell therapy; Clinical trials |
| Core Tip |
Pulmonary diseases across all ages threaten millions of people and have emerged as one of the major public health issues worldwide. Human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are superior for standardization and large-scale production for disease treatment. Herein, we provide a detailed summary of clinical trials and results related to the use of UC-MSCs in the treatment of lung diseases and explore in depth the challenges and opportunities faced in the clinical application of these cells. |
| Publish Date |
2024-02-26 04:10 |
| Citation |
Meng M, Zhang WW, Chen SF, Wang DR, Zhou CH. Therapeutic utility of human umbilical cord-derived mesenchymal stem cells-based approaches in pulmonary diseases: Recent advancements and prospects. World J Stem Cells 2024; 16(2): 70-88 |
| URL |
https://www.wjgnet.com/1948-0210/full/v16/i2/70.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v16.i2.70 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
